Twist Bioscience Corp

NASDAQ:TWST 4:00:00 PM EDT

36.79

+0.86 (+2.39%)

: $36.50 -0.29 (-0.79%)

Market Cap (Intraday)	2.20B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$95.36 Million
Adjusted EPS	-$0.52

See more estimates

10-Day MA	$35.86
50-Day MA	$33.71
200-Day MA	$41.87

See more pivots

Twist Bioscience Corp Stock, NASDAQ:TWST

681 Gateway Boulevard, San Francisco, California 94080

United States of America

Phone: +1.800.719.0671

Number of Employees: 923

http://www.twistbioscience.com

Description

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.